CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention

  1. Saiz-Rodríguez, M.
  2. Belmonte, C.
  3. Abad-Santos, F.
Revue:
Clinical Pharmacology and Therapeutics

ISSN: 1532-6535,  0009-9236

Année de publication: 2019

Volumen: 105

Número: 5

Pages: 1074-1075

Type: Lettre

DOI: 10.1002/CPT.1300 GOOGLE SCHOLAR

Objectifs de Développement Durable